As of April 2023, standard concentration of xylazine (20 mg/ml-AnaSed) is no longer available. This specific formulation was manufactured by a supplier (Akorn Pharmaceuticals) that has gone out of business and as such, the product has been discontinued. Currently, there are no other suppliers manufacturing a similar xylazine injectable product with a 20 mg/ml concentration. […]